Ulrich Reineke

This inventor holds 26 USPTO granted patents and 8 published patent applications, plus 7 CIPO patents and 12 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Baxalta Gmbh, Shire Orphan Therapies Gmbh, 3B Pharmaceuticals Gmbh. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ulrich Reineke. Retrieved from https://idiyas.com/inventor/ulrich-reineke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 8)

% Patents Active = 69.2

CIPO Patents = 7 (Patent Applications = 10)

EPO Patents = 12 (Patent Applications = 25)

Average Co-Inventor Count = 8.1

ph-index = 5

Forward Citations = 85(Granted Patents)

Company Filing History:

Shire Orphan Therapies Gmbh

patents

4 out of 7

3B Pharmaceuticals Gmbh

Baxter International Inc.

patents

6. 2 out of 1,228

Takeda Pharmaceutical Company Limited

Shire Orphan Thereapies Gmbh

patent

where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

Fibroblast Activation Protein

TFPI Inhibitors

Neurotensin Receptor Ligands

NPR-B Agonists

Integrin Inhibition

Angiogenesis Inhibition

Cyclic Peptides

C5a Receptor Antagonists

8-Oxy-Quinoline Derivatives

Heterocyclic Compounds

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12734259 - COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF (2026-09-15),

2. 12427210 - Compounds comprising a fibroblast activation protein ligand and use thereof (2025-09-30),

3. 11793855 - TFPI inhibitors and methods of use (2023-10-24),

4. 11001613 - TFPI inhibitors and methods of use (2021-05-11),

5. 10961199 - Neurotensin receptor ligands (2021-03-30),

6. 10800816 - TFPI inhibitors and methods of use (2020-10-13),

7. 10799605 - Conjugate comprising a neurotensin receptor ligand and use thereof (2020-10-13),

8. 10201586 - TFPI inhibitors and methods of use (2019-02-12),

9. 10196423 - NPR-B agonists (2019-02-05),

10. 9982016 - NPR-B agonists (2018-05-29),

11. 9873720 - TFPI inhibitors and methods of use (2018-01-23),

12. 9777051 - TFPI inhibitors and methods of use (2017-10-03),

13. 9745344 - NPR-B agonists (2017-08-29),

14. 9556230 - TFPI inhibitors and methods of use (2017-01-31),

15. 9458198 - Cyclic peptide-based NPR-B agonists (2016-10-04),

Title: Inventor Ulrich Reineke

Introduction: Ulrich Reineke is a renowned inventor based in Berlin, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Ulrich Reineke holds several patents in the areas of renewable energy, sustainable transportation, and advanced materials.

Career Highlights: With a career spanning over two decades, Ulrich Reineke has worked with leading research institutions and companies to develop innovative solutions that have had a significant impact on the industry.

Collaborations: Throughout his career, Ulrich Reineke has collaborated with top engineers, scientists, and designers to bring his inventions to life, fostering a culture of creativity and excellence.

Conclusion: Ulrich Reineke's passion for innovation and his dedication to pushing the boundaries of technology make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.